61 – 70 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Acceptance tests and criteria of the ATLAS transition radiation tracker
(
- Contribution to journal › Article
- 2004
-
Mark
Chance or necessity? Insertional mutagenesis in gene therapy and its consequences
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Efficient characterization of retro-, lenti-, and foamyvector-transduced cell populations by high-accuracy insertion site sequencing
2003) HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION: Fourth International Symposium 996. p.112-121(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2002
-
Mark
Prenatal development of gastrointestinal function in the pig and the effects of fetal esophageal obstruction
(
- Contribution to journal › Article
-
Mark
Transport of 222Rn using the regional model REMO : a detailed comparison with measurements over Europe
(
- Contribution to journal › Article
- 2001
-
Mark
High-titer lentivirus mediated gene transfer introduces multiple vector copies into the genome of primate and human hematopoietic repopulating cells
(
- Contribution to journal › Article
- 1998
-
Mark
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
(
- Contribution to journal › Article
- 1995
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
(
- Contribution to journal › Article
- 1994
-
Mark
Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy
(
- Contribution to journal › Article
-
Mark
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis
(
- Contribution to journal › Article